Search Results - "Gmucova, Hana"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Lymphocyte profile in peripheral blood of patients with multiple myeloma by Dekojová, Tereza, Gmucová, Hana, Macečková, Diana, Klieber, Robin, Ostašov, Pavel, Leba, Martin, Vlas, Tomáš, Jungová, Alexandra, Caputo, Valentina S, Čedíková, Miroslava, Lysák, Daniel, Jindra, Pavel, Holubová, Monika

    Published in Annals of hematology (04-06-2024)
    “…Multiple myeloma (MM) is a disease which remains incurable. One of the main reasons is a weakened immune system that allows MM cells to survive. Therefore, the…”
    Get full text
    Journal Article
  2. 2

    Improving the Clinical Application of Natural Killer Cells by Modulating Signals Signal from Target Cells by Holubova, Monika, Leba, Martin, Gmucova, Hana, Caputo, Valentina S, Jindra, Pavel, Lysak, Daniel

    “…Relapsed acute myeloid leukemia (AML) is a significant post-transplant complication lacking standard treatment and associated with a poor prognosis. Cellular…”
    Get full text
    Journal Article
  3. 3

    Dynamic Changes of Inhibitory Killer-Immunoglobulin-Like Receptors on NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation: An Initial Study by Dekojová, Tereza, Houdová, Lucie, Fatka, Jiří, Pitule, Pavel, Ostašov, Pavel, Caputo, Valentina S., Gmucová, Hana, Lysák, Daniel, Jindra, Pavel, Holubová, Monika

    Published in Journal of clinical medicine (29-10-2020)
    “…Killer-immunoglobulin-like receptors (KIRs) are critical natural killer (NK) cell regulators. The expression of KIRs is a dynamic process influenced by many…”
    Get full text
    Journal Article
  4. 4

    Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT by Machuldova, Alena, Houdova, Lucie, Kratochvilova, Katerina, Leba, Martin, Jindra, Pavel, Ostasov, Pavel, Maceckova, Diana, Klieber, Robin, Gmucova, Hana, Sramek, Jiri, Holubova, Monika

    Published in Journal of clinical medicine (09-10-2021)
    “…NKG2D and its ligands, MICA and MICB, are known as the key regulators of NK cells. NK cells are the first reconstituted cells after the allogeneic…”
    Get full text
    Journal Article